HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Castelli Selected Research

Thrombotic Microangiopathies

1/2020Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Castelli Research Topics

Disease

13Neoplasms (Cancer)
04/2024 - 05/2004
9Thrombosis (Thrombus)
04/2024 - 07/2010
8Multiple Myeloma
05/2022 - 07/2010
8Lymphoma (Lymphomas)
01/2020 - 07/2010
7Hemorrhage
02/2024 - 05/2004
5Infections
02/2024 - 12/2014
5Angioedema
08/2018 - 12/2008
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2017 - 05/2007
4Anemia
01/2019 - 09/2014
4Acquired angioedema
08/2018 - 12/2008
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2018 - 02/2013
4Paraproteinemias (Monoclonal Gammopathy)
12/2014 - 05/2007
3Iron Deficiencies
08/2022 - 01/2019
3Venous Thromboembolism
05/2022 - 05/2004
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2021 - 02/2013
2COVID-19
11/2023 - 04/2020
2Chronic Renal Insufficiency
01/2019 - 01/2019
2Essential Thrombocythemia
01/2019 - 01/2018
2Thrombocytopenia (Thrombopenia)
01/2019 - 01/2018
2Rare Diseases (Rare Disease)
08/2018 - 09/2013
2Thrombocytosis (Thrombocythemia)
01/2018 - 04/2015
2Hereditary Angioedemas
02/2013 - 05/2007
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2012 - 01/2002
1Wounds and Injuries (Trauma)
02/2024
1Thrombophlebitis
01/2024
1Sepsis (Septicemia)
11/2023
1Respiratory Insufficiency (Respiratory Failure)
11/2023
1Delirium
11/2023
1Hemophilia A (Haemophilia)
10/2022
1Melanoma (Melanoma, Malignant)
10/2022
1Refractory Anemia
08/2022
1Non-alcoholic Fatty Liver Disease
10/2021
1Weight Loss (Weight Reduction)
10/2021
1Asthma (Bronchial Asthma)
01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1Eosinophilia
01/2021
1Disseminated Intravascular Coagulation
01/2021
1Thromboembolism
04/2020

Drug/Important Bio-Agent (IBA)

5Rituximab (Mabthera)FDA Link
10/2022 - 01/2016
5AutoantibodiesIBA
10/2022 - 05/2007
4HematinicsIBA
08/2022 - 04/2018
4Epoetin Alfa (Epogen)FDA Link
01/2019 - 09/2014
4Biosimilar PharmaceuticalsIBA
01/2019 - 09/2014
4Complement System Proteins (Complement)IBA
08/2018 - 12/2008
3von Willebrand FactorIBA
04/2024 - 06/2012
3IronIBA
08/2022 - 01/2019
3CytokinesIBA
05/2022 - 07/2010
3C-Reactive ProteinIBA
10/2021 - 06/2012
3Bendamustine HydrochlorideFDA Link
01/2021 - 01/2016
3Heparin (Liquaemin)FDA LinkGeneric
01/2019 - 05/2004
3Immunomodulating AgentsIBA
12/2014 - 10/2012
3Peptides (Polypeptides)IBA
09/2013 - 12/2008
3BradykininIBA
09/2013 - 12/2008
2Factor VIII (Coagulation Factor VIII)IBA
04/2024 - 10/2022
2Monoclonal AntibodiesIBA
08/2023 - 08/2012
2Plasminogen Activators (Plasminogen Activator)IBA
10/2021 - 06/2012
2Factor VII (Proconvertin)IBA
10/2021 - 06/2012
2ThrombinFDA Link
10/2021 - 10/2011
2Fibrinogen (Factor I)FDA Link
10/2021 - 06/2012
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 07/2010
2Hemostatics (Antihemorrhagics)IBA
04/2020 - 12/2014
2Hemoglobins (Hemoglobin)IBA
01/2019 - 01/2019
2Thromboplastin (Tissue Factor)IBA
12/2014 - 07/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2014 - 07/2010
2EndotoxinsIBA
12/2014 - 07/2010
2GlycosaminoglycansIBA
12/2014 - 07/2010
2Factor XII (Hageman Factor)IBA
12/2014 - 07/2010
2AntibodiesIBA
09/2013 - 02/2010
1NivolumabIBA
10/2022
1pembrolizumabIBA
10/2022
1ferric carboxymaltoseIBA
08/2022
1AntigensIBA
10/2021
1HomocysteineIBA
10/2021
1LipidsIBA
10/2021
1Protein SIBA
10/2021
1Plasminogen Activator Inhibitor 1IBA
10/2021
1Retinoic Acid Receptor alphaIBA
10/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1Vincristine (Oncovin)FDA LinkGeneric
01/2021
1mepolizumabIBA
01/2021
1bosutinibIBA
01/2021
1eltrombopagFDA Link
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1ArsenicIBA
01/2021
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2021
1Prednisone (Sone)FDA LinkGeneric
01/2021
1Thrombopoietin ReceptorsIBA
11/2020
1Biomarkers (Surrogate Marker)IBA
01/2020

Therapy/Procedure

9Therapeutics
01/2021 - 05/2004
8Drug Therapy (Chemotherapy)
01/2020 - 07/2010
3Catheters
02/2024 - 11/2023
1Palliative Care (Palliative Therapy)
11/2023
1Continuous Positive Airway Pressure
11/2023
1Punctures
11/2023
1Immunotherapy
10/2022
1Blood Transfusion (Blood Transfusions)
08/2022
1Platelet Transfusion (Blood Platelet Transfusions)
01/2021